USA Markit Composite PMI for Aug 59.500 vs 59.700 consensus estimate. The prior reading was 60.200.
EF Hutton Initiates Coverage On Lantern Pharma with Buy Rating, Announces Price Target of $11
EF Hutton analyst Michael King initiates coverage on Lantern Pharma (NASDAQ:LTRN) with a Buy rating and announces Price Target of $11.